Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Tanvex BioPharma Inc (TW: 6541)

 
6541 Technical Analysis
3
As on 30th Jul 2025 6541 STOCK Price closed @ 51.40 and we RECOMMEND Sell for LONG-TERM with Stoploss of 57.70 & Sell for SHORT-TERM with Stoploss of 55.90 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

6541STOCK Price

Open 52.00 Change Price %
High 52.00 1 Day -0.50 -0.96
Low 51.10 1 Week -1.40 -2.65
Close 51.40 1 Month -0.20 -0.39
Volume 406033 1 Year -12.80 -19.94
52 Week High 81.80 | 52 Week Low 36.95
 
TW Taiwan Most Active Stocks
2888 11.80 3.96%
1303 38.70 7.95%
8033 95.30 9.92%
1802 21.75 0.93%
2027 40.45 2.15%
2408 44.90 6.40%
2887 16.40 1.23%
3706 77.30 2.66%
1326 29.50 9.46%
1301 42.65 9.92%
 
TW Taiwan Top Gainers Stocks
2429 88.10 9.99%
2429 88.10 9.99%
1301 42.65 9.92%
1301 42.65 9.92%
1301 42.65 9.92%
8033 95.30 9.92%
8033 95.30 9.92%
6505 43.25 9.91%
3543 39.45 9.89%
1605 22.90 9.83%
 
TW Taiwan Top Losers Stocks
3454 95.50 -10.33%
6289 1.35 -10.00%
3035 157.50 -9.22%
5871 118.00 -6.72%
2528 27.20 -5.56%
2528 27.20 -5.56%
2497 38.80 -5.37%
6591 63.50 -5.37%
6271 106.50 -5.33%
2376 268.50 -4.96%
 
 
6541
Daily Charts		 6541
Intraday Charts		 Whats New @
Bazaartrend		 6541
Free Analysis
 
6541 Important Levels Intraday
RESISTANCE53.13
RESISTANCE52.58
RESISTANCE52.23
RESISTANCE51.89
SUPPORT50.91
SUPPORT50.57
SUPPORT50.22
SUPPORT49.67
 
6541 Forecast July 2025
Share
4th UP Forecast66.62
3rd UP Forecast61.74
2nd UP Forecast58.72
1st UP Forecast55.71
1st DOWN Forecast47.09
2nd DOWN Forecast44.08
3rd DOWN Forecast41.06
4th DOWN Forecast36.18
 
6541 Weekly Forecast
4th UP Forecast58.34
3rd UP Forecast56.11
2nd UP Forecast54.74
1st UP Forecast53.36
1st DOWN Forecast49.44
2nd DOWN Forecast48.06
3rd DOWN Forecast46.69
4th DOWN Forecast44.46
 
6541 Forecast2025
4th UP Forecast141.87
3rd UP Forecast112.86
2nd UP Forecast94.92
1st UP Forecast76.99
1st DOWN Forecast25.81
2nd DOWN Forecast7.88
3rd DOWN Forecast-10.06
4th DOWN Forecast-39.07
 
 
6541 Other Details
Segment EQ
Market Capital 17741051904.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
6541 Address
6541
 
6541 Latest News
 
Your Comments and Response on Tanvex BioPharma Inc
 
6541 Business Profile
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar and biologic products and drugs in Taiwan and the United States. The company's lead product candidate includes TX01 for the treatment of neutropenia. It also develops TX05, which has completed phase III clinical trial for the treatment of breast cancer; TX04 for the treatment of neutropenia; TX16 that has completed phase I clinical trial for the treatment of metastatic colorectal cancer; TX52, which is in pre-clinical trial; and other products. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands. Address: 802 West Bay Road, George Town, Cayman Islands, KY1-1205
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service